Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-hodgkin lymphomas

Scandinavian Journal of Immunology

Volumn 71, Issue 1, 2009, Pages 29-37

  Hajdu, M ^a   Kopper, L ^a   Sebestyen A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DELTA LIKE 4; GAMMA SECRETASE INHIBITOR; MYC PROTEIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; NONHODGKIN LYMPHOMA; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 72349088536     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02346.x     Document Type: Article

References (44)

1. Ohishi K, Katayama N, Shiku H, Varnum-Finney B, Bernstein ID. Notch signalling in hematopoiesis. Semin Cell Dev Biol 2003 14 : 143 150.
2. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000 228 : 151 165.
3. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T-cell acute lymphoblastic leukemia. Science 2004 306 : 269 271.
4. Jundt F, Anagnostopoulos I, Förster R, Mathas S, Stein H, Dörken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002 99 : 3398 3403.
5. Jundt T, Acikgöz Ö, Kwon S-H, et al. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin-lymphoma. Leukemia 2008 22 : 1587 1594.
6. Hubmann R, Schwarzmeier JD, Shehata M, et al. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood 2002 99 : 3742 3747.
7. Duechler M, Shehata M, Schwarzmeier JD, Hoelbl A, Hilgarth M, Hubmann R. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia 2005 19 : 260 267.
8. Rosati E, Sabatini R, Rampino G, et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009 113 : 856 865.
9. Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 2004 103 : 3503 3510.
10. Jundt F, Pröbsting KS, Anagnostopoulos I, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 2004 103 : 3511 3515.
11. Hajdu M, Sebestyén A, Barna G, et al. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells. Scand J Immunol 2007 65 : 271 275.
12. Zweidler-McKay PA, He Y, Xu L, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B cell malignancies. Blood 2005 106 : 3898 3906.
13. Deangelo DJ, Stone RM, Silverman LB, et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. Abstract. J Clin Oncol 2006 24 : 6585.
14. Miele L Gamma-Secretase and Notch Signaling: Novel Therapeutic Targets in Breast Cancer, 2005. http://stinet.dtic.mil/oai/oai?verb= getRecord&metadataPrefix=html&identifier=ADA446389.r
15. Tohda S, Sato T, Kogoshi H, Fu L, Sakano S, Nara N. Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors. Leuk Res 2006 30 : 1385 1390.
16. Kogoshi H, Sato T, Koyama T, Nara N, Tohda S. γ-secretase inhibitors suppress the growth of leukemia and lymphoma cell lines. Oncol Rep 2007 18 : 77 80.
17. Li MO, Wan YY, Sanjabi S, Robertson AL, Flavell RA. Transforming growth factor-β regulation of immune responses. Ann Rev Immunol 2006 24 : 4.
18. Siegel PM, Massagué J. Cytostatic and apoptotic actions of TGFb in homeostasis and cancer. Nat Rev Cancer 2003 3 : 807 821.
19. Lin HK, Bergmann S, Pandolfi P. Deregulated TGFb signaling in leukemogenesis. Oncogene 2005 24 : 5693 5700.
20. Zavadil J, Cermak L, Soto-Nieves N, Böttinger EP. Integration of TGF-b/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004 23 : 1155 1165.
21. Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGFb. J Cell Biol 2007 176 : 695 707.
22. Blokzijl A, Dahlqvist C, Reissmann E, et al. Cross-talk between the Notch and TGFb signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 2003 163 : 723 728.
23. Kopper L, Bánkfalvy A, Mihalik R, Nagy P, Fülöp C, Sármay G. New in vitro line from a human (B) non-Hodgkin lymphoma. Anticancer Res 1991 11 : 1645 1650.
24. Végsülloi G, Sebestyén A, Paku S, et al. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leuk Res 2007 31 : 1003 1008.
25. Mihalik R, Uher F, Pocsik É, Berczi L, Benczur M, Kopper L. Detection of drug-induced apoptosis by flow cytometry after alkaline extraction of ethanol fixed cells. Pathol Oncol Res 1996 2 : 78 83.
26. Morimura T, Goitsuka R, Zhang Y, Saito I, Reth M, Kitamura D. Cell cycle arrest and apoptosis induced by notch1 in B cells. J Biol Chem 2000 275 : 36523 36531.
27. Romer S, Saunders U, Jäck HM, Jehn BM. Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression. Cell Death Diff 2003 10 : 833 844.
28. He F, Wang L, Hu XB, et al. Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells. Leuk Res 2009 33 : 798 802.
29. Colaluca IN, Tosoni D, Nuciforo P, et al. NUMB controls p53 tumour suppressor activity. Nature 2008 451 : 76 81.
30. Geling A, Steiner H, Willem M, Bally-Cuif L, Haass C. A γ-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Reports 2002 3 : 6886 6694.
31. Bheeshmachar G, Purushotaman D, Sade H, Gunasekharan V, Rangarajan A, Sarin A. Evidence for a role for Notch signaling in the cytokine-dependent survival of activated T-Cells. J Immunol 2006 177 : 5041 5050.
32. De Smedt M, Hoebeke I, Reynvoet K, Leclercq G, Plum J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood 2005 106 : 3498 3506.
33. Sjölund J, Johansson M, Manna S, et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008 118 : 217 228.
34. De Keersmaecker K, Lahortiga I, Mentens N, et al. In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica 2008 93 : 533 542.
35. Wong GT, Manfra D, Poulet FM, et al. Chronic treatment with the g-secretase inhibitor LY-411,575 inhibits b-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Cell Biochem 2004 279 : 12876 12882.
36. Van Es JH, Van Gijn ME, Riccio O, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005 435 : 959 963.
37. De La Coste A, Freitas AA. Notch signaling: Distinct ligands induce specific signals during lymphocyte development and maturation. Immunol Letters 2006 102 : 1 9.
38. Vas V, Szilágyi L, Pálóczi K, Uher F. Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay. J Leukoc Biol 2004 75 : 714 720.
39. Varnum-Finney B, Wu L, Yu M, et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci 2000 23 : 4313 4318.
40. Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood 1997 89 : 941 947.
41. Lagneaux L, Delforge A, Bernier M, Stryckmans P, Bron D. TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia. Leuk Lmyphoma 1998 31 : 99 106.
42. Cullion K, Draheim KM, Hermance N, et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 2009 113 : 6172 6181.
43. Sharma VM, Calvo JA, Draheim KM, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 2006 26 : 8022 8031.
44. Sharma VM, Draheim KM, Kelliher MA. The notch1/c-Myc pathway in T-cell leukemia. Cell Cycle 2007 6 : 927 930.